Repare Therapeutics Inc expected to post a loss of 74  cents a share - Earnings Preview

Repare Therapeutics

28/02/2022 22:43

* Repare Therapeutics Inc  RPTX.OQ   RPTX.O  is expected
to show a
rise in quarterly revenue when it reports  results on March 2
(estimated). 
    * The St-laurent Quebec-based  company is expected to report
 a
2,327.3% increase in revenue to $3.277 million from $135
thousand a year ago, according to the mean estimate from 7
analysts, based on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for Repare Therapeutics
Inc
is for a loss of 74 cents per share. For the same quarter last
year, the company reported a loss of 41 cents per share.
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 9 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Repare
Therapeutics Inc is $45​, about 65.8% above​ its last closing
price of $15.37. ​​​
    * Previous quarterly performance (using preferred earnings
measure
in US dollars). ​

 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Sep. 30 2021  -0.71       -0.71      -0.83     Missed  -16.9
 Jun. 30 2021  -0.60       -0.60      -0.71     Missed  -17.4
 Mar. 31 2021  -0.51       -0.51      -0.58     Missed  -14.6​
 Dec. 31 2020  -0.40       -0.39      -0.41     Missed  -3.8
 ​​Sep.        -0.39       -0.38      -0.37     Beat    2.2
 30 2020                                                
 Jun. 30 2020  -0.05       -0.06      -2.45     Missed  -4,160
                                                        .9​
 This summary was machine generated February 28 at 22:41 GMT. 
All figures in US dollars  unless otherwise stated